U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07195916) titled 'A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies' on Sept. 19.
Brief Summary: A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.
Study Start Date: Dec. 31, 2025
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Hematologic Malignancies
Intervention:
DRUG: INCA036873
Intravenously (IV)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Incyte Corporation
Disclaimer: Curated by HT Syndication....